HPK1 as a novel target for cancer immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Immunology
Link
http://link.springer.com/content/pdf/10.1007/s12026-012-8319-1.pdf
Reference25 articles.
1. Thiesing JT, Ohno-Jones S, Kolibaba KS, Druker BJ. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. Blood. 2000;96(9):3195–9.
2. Cervantes F, Mauro M. Practical management of patients with chronic myeloid leukemia. Cancer. 2011;117(19):4343–54.
3. Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther. 2006;6(12):1323–31.
4. Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol. 2005;23(9):1147–57.
5. Riley JL, June CH. The road to recovery: translating PD-1 biology into clinical benefit. Trends Immunol. 2007;28(2):48–50.
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of an Exceptionally Orally Bioavailable and Potent HPK1 PROTAC with Enhancement of Antitumor Efficacy of Anti-PD-L1 Therapy;Journal of Medicinal Chemistry;2024-07-31
2. Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation;PLOS ONE;2024-06-26
3. HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics;Nature Communications;2024-05-02
4. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress;Expert Opinion on Therapeutic Targets;2024-04-02
5. Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody;European Journal of Medicinal Chemistry;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3